# Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.

> **NCT06846073** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 70 (estimated)

## Conditions studied

- Diabetic Macular Edema (DME)

## Interventions

- **COMBINATION_PRODUCT:** The combination of intravitreal anti-VEGF and dexamethasone implants injections.

## Key facts

- **NCT ID:** NCT06846073
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06846073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06846073, "Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06846073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*